Search research articles
Contact Us
Filters
Showing results (121-130 of 195) with videos related to
Page
of 20
Sort By:
Theranostics
|
November 18, 2020
Urinary glycoproteins associated with aggressive prostate cancer
Mingming Dong, T Mamie Lih, Shao-Yung Chen, et al.
Journal of the National Cancer Institute
|
November 21, 2002
Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer
Hsueh-Wei Chang, Shing M Lee, Steven N Goodman, et al.
Journal of Hematology & Oncology
|
December 8, 2020
Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets
Yangying Zhou, T Mamie Lih, Jianbo Pan, et al.
Theranostics
|
May 17, 2021
A panel of selected serum protein biomarkers for the detection of aggressive prostate cancer
Jin Song, Shiyong Ma, Lori J Sokoll, et al.
Urology
|
October 18, 2002
Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter
Wolfgang Horninger, Carol D Cheli, Richard J Babaian, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
May 1, 2012
Multi-center analytical performance evaluation of the Access Hybritech® p2PSA immunoassay
Lori J Sokoll, Daniel W Chan, George G Klee, et al.
Urology
|
December 11, 2003
Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer
Yoshio Naya, Herbert A Fritsche, Carol D Cheli, et al.
The Journal of Urology
|
April 17, 2002
Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer
Koji Okihara, Carol D Cheli, Alan W Partin, et al.
Urology
|
October 18, 2002
Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?
Yoshio Naya, Thomas A Stamey, Carol D Cheli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2004
Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers
Jens Koopmann, Phillip Buckhaults, David A Brown, et al.
Page
of 20
Search research articles
Search
Showing results (121-130 of 195) with videos related to
Sort By:
Page
of 20
Theranostics
|
November 18, 2020
Urinary glycoproteins associated with aggressive prostate cancer
Mingming Dong, T Mamie Lih, Shao-Yung Chen, et al.
Journal of the National Cancer Institute
|
November 21, 2002
Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer
Hsueh-Wei Chang, Shing M Lee, Steven N Goodman, et al.
Journal of Hematology & Oncology
|
December 8, 2020
Proteomic signatures of 16 major types of human cancer reveal universal and cancer-type-specific proteins for the identification of potential therapeutic targets
Yangying Zhou, T Mamie Lih, Jianbo Pan, et al.
Theranostics
|
May 17, 2021
A panel of selected serum protein biomarkers for the detection of aggressive prostate cancer
Jin Song, Shiyong Ma, Lori J Sokoll, et al.
Urology
|
October 18, 2002
Complexed prostate-specific antigen for early detection of prostate cancer in men with serum prostate-specific antigen levels of 2 to 4 nanograms per milliliter
Wolfgang Horninger, Carol D Cheli, Richard J Babaian, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
May 1, 2012
Multi-center analytical performance evaluation of the Access Hybritech® p2PSA immunoassay
Lori J Sokoll, Daniel W Chan, George G Klee, et al.
Urology
|
December 11, 2003
Volume indexes of total, free, and complexed prostate-specific antigen enhance prediction of extraprostatic disease extension in men with nonpalpable prostate cancer
Yoshio Naya, Herbert A Fritsche, Carol D Cheli, et al.
The Journal of Urology
|
April 17, 2002
Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer
Koji Okihara, Carol D Cheli, Alan W Partin, et al.
Urology
|
October 18, 2002
Can volume measurement of the prostate enhance the performance of complexed prostate-specific antigen?
Yoshio Naya, Thomas A Stamey, Carol D Cheli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 10, 2004
Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers
Jens Koopmann, Phillip Buckhaults, David A Brown, et al.
Page
of 20